Figure 9.Drug sensitivity analysis between the ICDRG score subtypes. (A–D) IPS evaluation shows the response to PD-1 and CTLA-4 of GC in ICDRG score subtypes. (E–P) Prediction of chemotherapy drug for GC in ICDRG score subgroups.
Figure 9 — Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma | Aging
